These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4768378)

  • 21. [Renal osteopathy. Metabolism and absorption of calcium in chronically haemodialyzed patients].
    Kocián J; Sotorník I
    Cas Lek Cesk; 1982 Jun; 121(24):756-9. PubMed ID: 7116378
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum phosphorus control in dialysis patients with aluminum hydroxide gel-containing cookies.
    Ogden DA; Hurley E; Witt E; Heitsman C; Cazee C
    Proc Clin Dial Transplant Forum; 1972; 2():166-70. PubMed ID: 4681306
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of chronic dialysis and renal transplantation on the metabolism of calcium and phosphate in renal osteodystrophy.
    van Amstel WJ; de Graeff J
    Folia Med Neerl; 1968; 11(5):201-8. PubMed ID: 4886564
    [No Abstract]   [Full Text] [Related]  

  • 24. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency].
    Pérez-García R; Jofre R; Vasconez F; Caballero A; Valderrábano F
    Rev Clin Esp; 1982 Feb; 164(3):159-52. PubMed ID: 7089332
    [No Abstract]   [Full Text] [Related]  

  • 26. Aluminum load and histological bone disease in hemofiltration and hemodialysis.
    Fournier A; Moriniere P; Fohrer P; Leflon P; de Fremont JF; Marié A; Westeel PF; Renaud H; Tahiri Y; Idrissi A
    Kidney Int Suppl; 1988 Mar; 24():S168-70. PubMed ID: 3163040
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal osteodystrophy. II. Pathology and roentgen diagnosis].
    Raber-Durlacher JE; Schächter ME; Abraham-Inpijn L; Bras J; van Ooij CP; Wilmink JM
    Ned Tijdschr Geneeskd; 1983 Aug; 127(35):1578-84. PubMed ID: 6633697
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of acute hypercalcemia on renal clearance of calcium and phosphorus in chronic uremia].
    Mioni G; Huber W; Bazzato G; D'Angelo A; Ossi E; Bertaglia E; Maschio G
    Minerva Nefrol; 1970; 17(3):75-82. PubMed ID: 5515029
    [No Abstract]   [Full Text] [Related]  

  • 29. [Structural changes and vascular calcifications in uremia].
    Caramelo C; Goicoechea M; Albalate M; Nieto L; Melero R; Berlanga JR; López MD; González Pacheco F; Marrón B; Alvarez Arroyo MV; Castilla MA; Yagüe S; Deudero JJ; Ortiz A
    Nefrologia; 2001; 21(6):538-47. PubMed ID: 11881423
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium and phosphorus metabolism and bone disease in uremia.
    Kleeman CR; Massry SG; Coburn JW; Popovtzer MM
    Clin Orthop Relat Res; 1970; 68():210-37. PubMed ID: 4905786
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of diet, dialysis and transplantation on bone lesions in chronic uraemia.
    Bonomini V; Albertazzi A; Bortolotti GC; Vangelista A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):324-31. PubMed ID: 4606504
    [No Abstract]   [Full Text] [Related]  

  • 32. [Renal osteodystrophy].
    Heidbreder E; Hennemann H; Heidland A
    Med Welt; 1974 Apr; 25(17):736-44. PubMed ID: 4370635
    [No Abstract]   [Full Text] [Related]  

  • 33. [Skeletal histology in uremic osteodystrophy following increase of dialysate calcium concentration to 3,75 mval-1 (preliminary report)].
    Malluche HH; Ritz E; Koch KM; Krempien B; Schoeppe W
    Verh Dtsch Ges Inn Med; 1973; 79():729-31. PubMed ID: 4789966
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of calcium and phosphorus in hemodialysis.
    Goldsmith RS
    Annu Rev Med; 1976; 27():181-90. PubMed ID: 180871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soft tissue calcification in chronic dialysis patients.
    Kuzela DC; Huffer WE; Conger JD; Winter SD; Hammond WS
    Am J Pathol; 1977 Feb; 86(2):403-24. PubMed ID: 836675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 37. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of dihydrotachysterol (DHT) on calcium metabolism in uremia.
    Asad S; Ellis K; Cohn S; Letter J
    Trans Am Soc Artif Intern Organs; 1974; 20A():142-7. PubMed ID: 4450332
    [No Abstract]   [Full Text] [Related]  

  • 39. 24,25 dihydroxycalciferol: assay in non-anephric patients on chronic haemodialysis and assessment of its possible pathophysiological role in renal osteodystrophy.
    Lambrey G; Nguyen TM; Fournier A; Sebert JL; Kassouf J; de Fremont JF; Marie P; Meunier P; Caillens C; Gueris J; Garabedian M; Balsan S
    Proc Eur Dial Transplant Assoc; 1980; 17():548-56. PubMed ID: 6972530
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term dialysis and its problems: calcium and phosphorus metabolism disorders, aluminum balance, and esteodystrophy].
    Kurokawa K
    Nihon Rinsho; 1980 Jun; 38(6):2329-36. PubMed ID: 6997567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.